Dipna Pharmachem Limited (BOM:543594)
India · Delayed Price · Currency is INR 5.50
-0.40 (-6.78%)
At close: Aug 25, 2026
Dipna Pharmachem Market Cap
Dipna Pharmachem has a market cap or net worth of 144.59 million as of August 25, 2026. Its market cap has decreased by -69.86% in one year.
Market Cap
144.59M
Enterprise Value
264.78M
Revenue
1.29B
Ranking
n/a
PE Ratio
5.50
Stock Price
5.50
ChartMarket Cap Chart
Since September 8, 2022, Dipna Pharmachem's market cap has decreased from 399.80M to 144.59M, a decrease of -63.83%. That is a compound annual growth rate of -22.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 144.59M | -67.46% |
| Dec 30, 2025 | 444.29M | 28.22% |
| Dec 31, 2024 | 346.49M | 171.80% |
| Dec 29, 2023 | 127.48M | -47.79% |
| Dec 30, 2022 | 244.19M | -38.92% |
| Sep 8, 2022 | 399.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Goldline Pharmaceutical | 393.31M |
| Chandra Bhagat Pharma | 376.50M |
| Medico Intercontinental | 291.70M |
| Medistep Healthcare | 269.27M |
| Pentokey Organy (India) | 206.87M |
| Centuple Global | 189.48M |
| Zenlabs Ethica | 169.26M |
| Muller & Phipps (India) | 137.09M |